rs17170073

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.97+260294C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0897 in 152,076 control chromosomes in the GnomAD database, including 950 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.090 ( 950 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.150

Publications

5 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.97+260294C>T intron_variant Intron 1 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.97+260294C>T intron_variant Intron 1 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.97+260294C>T intron_variant Intron 1 of 23 1 NM_014141.6 ENSP00000354778.3
CNTNAP2ENST00000625365.2 linkc.97+260294C>T intron_variant Intron 2 of 3 5 ENSP00000485955.1
CNTNAP2ENST00000637150.1 linkn.26+260294C>T intron_variant Intron 1 of 8 5

Frequencies

GnomAD3 genomes
AF:
0.0897
AC:
13625
AN:
151958
Hom.:
950
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.189
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0517
Gnomad ASJ
AF:
0.0737
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.0716
Gnomad FIN
AF:
0.0230
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.0575
Gnomad OTH
AF:
0.0908
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0897
AC:
13646
AN:
152076
Hom.:
950
Cov.:
32
AF XY:
0.0856
AC XY:
6366
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.189
AC:
7845
AN:
41466
American (AMR)
AF:
0.0514
AC:
785
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0737
AC:
255
AN:
3460
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5168
South Asian (SAS)
AF:
0.0717
AC:
345
AN:
4812
European-Finnish (FIN)
AF:
0.0230
AC:
244
AN:
10596
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.0575
AC:
3911
AN:
67980
Other (OTH)
AF:
0.0913
AC:
193
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
594
1189
1783
2378
2972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0720
Hom.:
705
Bravo
AF:
0.0952
Asia WGS
AF:
0.0500
AC:
176
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.9
DANN
Benign
0.46
PhyloP100
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17170073; hg19: chr7-146074359; API